Top

Published in:

01-10-2015 | Review Article

Quantitative MR Imaging of Brain Tissue and Brain Pathologies

Authors: E. Hattingen, A. Jurcoane, M. Nelles, A. Müller, U. Nöth, B. Mädler, P. Mürtz, R. Deichmann, H. H. Schild

Published in: Clinical Neuroradiology | Special Issue 2/2015

Abstract

Measurement of basic quantitative magnetic resonance (MR) parameters (e.g., relaxation times T1, T2*, T2 or respective rates R (1/T)) corrected for radiofrequency (RF) coil bias yields different conventional and new tissue contrasts as well as volumes for tissue segmentation. This approach also provides quantitative measures of microstructural and functional tissue changes. We herein demonstrate some prospects of quantitative MR imaging in neurological diagnostics and science.

Cheng HL, Stikov N, Ghugre NR, Wright GA. Practical medical applications of quantitative MR relaxometry. J Magn Reson Imaging. 2012;36:805–24.CrossRefPubMed

Tofts P, editor. Quantitative MRI of the brain: measuring changes caused by disease. Chichester: Wiley; 2003. pp. 272–98).CrossRef

Komiyama M, Yagura H, Baba M, Yasui T, Hakuba A, Nishimura S, Inoue Y. MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. AJNR Am J Neuroradiol. 1987;8:65–70.PubMed

Kjaer L, Thomsen C, Gjerris F, Mosdal B, Henriksen O. Tissue characterization of intracranial tumors by MR imaging. In vivo evaluation of T1- and T2-relaxation behavior at 1.5 T. Acta Radiol. 1991;32:498–504.PubMed

Hoehn-Berlage M, Bockhorst K. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues. Technol Health Care. 1994;2:247–54.PubMed

Miot E, Hoffschir D, Alapetite C, Gaboriaud G, Pontvert D, Fetissof F, Pape AL, Akoka S. Experimental MR study of cerebral radiation injury: quantitative T2 changes over time and histopathologic correlation. AJNR Am J Neuroradiol. 1995;16:79–85.PubMed

Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J Neurol. 2002;249:1279–86.CrossRefPubMed

Mamere AE, Saraiva LA, Matos AL, Carneiro AA, Santos AC. Evaluation of delayed neuronal and axonal damage secondary to moderate and severe traumatic brain injury using quantitative MR imaging techniques. AJNR Am J Neuroradiol. 2009;30:947–52.CrossRefPubMed

Vrenken H, Geurts JJ, Knol DL, Polman CH, Castelijns JA, Pouwels PJ, Barkhof F. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR Am J Neuroradiol. 2006;27:2005–11.PubMed

10.

Ropele S, Langkammer C, Enzinger C, Fuchs S, Fazekas F. Relaxation time mapping in multiple sclerosis. Expert Rev Neurother. 2011;11:441–50.CrossRefPubMed

11.

MacKay AL, Vavasour IM, Rauscher A, Kolind SH, Mädler B, Moore GR, Traboulsee AL, Li DK, Laule C. MR relaxation in multiple sclerosis. Neuroimaging Clin N Am. 2009;19:1–26.CrossRefPubMed

12.

Papadopoulos K, Tozer DJ, Fisniku L, Altmann DR, Davies G, Rashid W, Thompson AJ, Miller DH, Chard DT. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Mult Scler. 2010;16:427–33.CrossRefPubMed

13.

Hasan KM, Walimuni IS, Abid H, Datta S, Wolinsky JS, Narayana PA. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS. J Neurol Sci. 2012;313:99–109.CrossRefPubMedCentralPubMed

14.

Jurcoane A, Wagner M, Schmidt C, Mayer C, Gracien RM, Hirschmann M, Deichmann R, Volz S, Ziemann U, Hattingen E. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis. J Magn Reson Imaging. 2013;38:1454–61.CrossRefPubMed

15.

Warntjes JB, Leinhard OD, West J, Lundberg P. Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med. 2008;60:320–9.CrossRefPubMed

16.

Nöth U, Hattingen E, Bähr O, Tichy J, Deichmann R. Improved visibility of brain tumors in synthetic MP-RAGE anatomies with pure T(1) weighting. NMR Biomed. 2015;28:818–30.CrossRefPubMed

17.

Preibisch C, Deichmann R. T1 mapping using spoiled FLASH-EPI hybrid sequences and varying flip angles. Magn Reson Med. 2009;62:240–6.CrossRefPubMed

18.

Volz S, Nöth U, Rotarska-Jagiela A, Deichmann R. A fast B1-mapping method for the correction and normalization of magnetization transfer ratio maps at 3 T. Neuroimage. 2010;49:3015–26.CrossRefPubMed

19.

Freeman AJ, Gowland PA, Mansfield P. Optimization of the ultrafast Look-Locker echo-planar imaging T1 mapping sequence. Magn Reson Imaging. 1998;16:765–72.CrossRefPubMed

20.

Hattingen E, Jurcoane A, Daneshvar K, Pilatus U, Mittelbronn M, Steinbach JP, Bähr O. Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. Neuro Oncol. 2013;15:1395–404.CrossRefPubMedCentralPubMed

21.

Lescher S, Jurcoane A, Veit A, Bähr O, Deichmann R, Hattingen E. Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI. Neuroradiology. 2015;57:11–20.CrossRefPubMed

22.

Remmele S, Sprinkart AM, Müller A, Träber F, von Lehe M, Gieseke J, Flacke S, Willinek WA, Schild HH, Sénégas J, Keupp J, Mürtz P. Dynamic and simultaneous MR measurement of R1 and R2* changes during respiratory challenges for the assessment of blood and tissue oxygenation. Magn Reson Med. 2013;70:136–46.CrossRefPubMed

23.

Matsumoto K, Bernardo M, Subramanian S, Choyke P, Mitchell JB, Krishna MC, Lizak MJ. MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn Reson Med. 2006;56:240–6.CrossRefPubMed

24.

Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic-resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990;14:68–78.CrossRefPubMed

25.

Müller A, Remmele S, Wenningmann I, Clusmann H, Träber F, Flacke S, König R, Gieseke J, Willinek WA, Schild HH, Mürtz P. Analysing the response in R2* relaxation rate of intracranial tumours to hyperoxic and hypercapnic respiratory challenges: initial results. Eur Radiol. 2011;21:786–98.CrossRefPubMed

Title: Quantitative MR Imaging of Brain Tissue and Brain Pathologies
Authors: E. Hattingen
A. Jurcoane
M. Nelles
A. Müller
U. Nöth
B. Mädler
P. Mürtz
R. Deichmann
H. H. Schild
Publication date: 01-10-2015
Publisher: Springer Berlin Heidelberg
Published in: Clinical Neuroradiology / Issue Special Issue 2/2015
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI: https://doi.org/10.1007/s00062-015-0433-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Quantitative MR Imaging of Brain Tissue and Brain Pathologies

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2015

Intraoperative MR Imaging in Neurosurgery

Geschichte der Neuroradiologie in Deutschland

Analyse zur Internetpräsenz der Deutschen Gesellschaft für Neuroradiologie

Flat-Panel Computed Tomography (DYNA-CT) in Neuroradiology. From High-Resolution Imaging of Implants to One-Stop-Shopping for Acute Stroke

Anfänge und Entwicklungen der endoluminalen neurovaskulären Therapie

Advanced MR Imaging in Neuro-oncology